Priority Review Voucher
Federal · 11-50 Employees
View Company Info for Free
Overview
Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Priority Review Voucher
The Priority Review Voucher Program, established by the US Congress in 2007, aims to expedite the regulatory review process for treatments targeting neglected diseases, rare pediatric diseases, and medical countermeasures. It allows the voucher holder to receive a faster review from the FDA, potentially benefiting both small and large pharmaceutical companies. The program encourages the development of essential therapies by providing a financial incentive through the sale of vouchers. Overall, it seeks to enhance access to critical treatments for patients in need while also supporting the pharmaceutical industry's innovation efforts.Explore more
Popular SearchesPriority Review VoucherSIC Code 96,961NAICS Code 92,926Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Priority Review Voucher your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Priority Review Voucher has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Priority Review Voucher
Check out if Priority Review Voucher is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Priority Review Voucher has new funding data
Click to see if Priority Review Voucher had a recent Job posting/layoffs
Priority Review Voucher, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Priority Review Voucher recently announced quarterly report
Product Launch: Get notified when Priority Review Voucher launches new products
Recommended Actions
Find VP level buyers at Priority Review Voucher
Find more new buyers
Priority Review Voucher Tech Stack
A closer look at the technologies used by Priority Review Voucher
See more technologies
Priority Review Voucher News & Media
Eiger BioPharmaceuticals Sells Priority Review Voucher for $95 Million
PALO ALTO, Calif., Nov. 23, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that it has entered into a definitive agreement to sell its...argenx Enters Into Agreement To Acquire Priority Review Voucher
November 23, 2020 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that the company has agreed to acquire a U.S. Food and Drug Administration (FDA) Priority Review Voucher (PRV) from Bayer Healthcare Pharmaceuticals, Inc for $98 million. A PRV entitles the holder to FDA priority review of
Read more news
Top Federal Companies
See more top companies
Frequently Asked Questions Regarding Priority Review Voucher
Sign Up For FreeTo access detailed company insights
The Priority Review Voucher Program, established by the US Congress in 2007, aims to expedite the regulatory review process for treatments targeting neglected diseases, rare pediatric diseases, and medical countermeasures. It allows the voucher holder to receive a faster review from the FDA, potentially benefiting both small and large pharmaceutica... Read More
